XML 29 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Feb. 15, 2022
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Period End Date Dec. 31, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus FY  
Entity Registrant Name RxSight, Inc.  
Entity Central Index Key 0001111485  
Entity Tax Identification Number 94-3268801  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Voluntary Filers Yes  
Entity Well-known Seasoned Issuer No  
Entity Filer Category Non-accelerated Filer  
Entity File Number 001-40690  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Small Business true  
Entity Interactive Data Current Yes  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 100 Columbia  
Entity Address, City or Town Aliso Viejo  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92656  
City Area Code 949  
Local Phone Number 521-7830  
Trading Symbol RXST  
Title of 12(b) Security Common stock, $0.001 par value per share  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   27,417,993
Document Annual Report true  
Document Transition Report false  
Entity Public Float $ 236  
ICFR Auditor Attestation Flag false  
Documents Incorporated by Reference

The Registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended December 31, 2021. Portions of such definitive proxy statement are incorporated by reference into Part III of this Annual Report on Form 10-K.

  
Auditor Name Ernst & Young, LLP  
Auditor Location Irvine, California  
Auditor Firm ID 42